Yoryos (georgios) Lyratzopoulos MD, FFPH, FRCP, MPH, DTM&H

Yoryos (Georgios) Lyratzopoulos, MD, FFPH, FRCP, MPH, DTM&H, is Professor of Cancer Epidemiology and Cancer Research UK Advanced Clinician Scientist Fellow at University College London (UCL). He leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group; and the UCL component of the CanTest Research Collaborative, supported by the inaugural Cancer Research UK Population Health Catalyst award (https://www.cantest.org). He is also part-time affiliated to the University of Cambridge and the Public Health England National Cancer Registration and Analysis Service. His research focuses on the predictors and outcomes of diagnostic timeliness in the diagnostic process for cancer patients who present with symptoms; the evaluation of new diagnostic strategies; and cancer patient experience. Mr Lyratzopoulos was previously National Institute for Health Research (UK) Post-Doctoral Fellow (2012-14) and has worked in the English National Health Service as a hospital doctor (internal medicine) and as a public health physician. He has also worked as clinical adviser to NICE’s interventional Procedures Programme 2006-2011. To June 2017, he has published over 140 peer-reviewed papers, two thirds of which as first/last author http://tinyurl.com/lncqq7f . He was awarded the Cancer Research UK ‘Future Leaders’ Prize in 2016, which recognises individuals who have produced world-leading research during their first 10 post-doctoral years.